由于SLC46A1缺乏而导致的叶酸限制,通过表观遗传转录重编程抑制了结直肠癌的进展
Yelu Zhou1, Yanxing Liu1, Yi Liu2
1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.
Cell death & disease
|January 31, 2026
概括
叶酸转运体SLC46A1通过维持DNA甲基化来抑制结肠直肠癌 (CRC). 它在CRC中的降低调节会损害叶酸的吸收,导致DNA低甲基化和激活瘤基因,推动瘤的进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 叶酸代谢在结肠直肠癌 (CRC) 发展中的作用受到争议.
- 叶酸载体SLC46A1的表达对于叶酸在CRC中的瘤抑制作用至关重要.
研究的目的:
- 研究叶酸载体SLC46A1在结肠直肠癌中的瘤抑制作用.
- 阐明SLC46A1,叶酸代谢和CRC进展之间的分子机制.
主要方法:
- 在CRC组织中SLC46A1表达的多队列分析.
- 在体外和体外功能研究评估SLC46A1对瘤细胞行为的影响.
- 细胞内叶酸水平,甲基化潜力 (SAM/SAH比率) 和DNA甲基化模式的分析.
- 免疫光检测用于评估SLC46A1和FOS在原发性和转移性瘤中的表达.
主要成果:
- 在CRC组织中,SLC46A1显著下调,与生存率差相关.
- 通过SLC46A1介导的叶酸吸收抑制了CRC细胞的增殖,迁移和入侵.
- 缺少SLC46A1会导致FOS促进体的甲基化和DNA低甲基化受损.
- 这种表观遗传重编程激活瘤基因 (CCND1,BCL2,PLAU),促进CRC的进展.
- 在瘤间位液中观察到SLC46A1表达和叶酸水平之间的反相关性.
结论:
- 叶酸转运体SLC46A1在CRC中起着关键的瘤抑制作用.
- 在CRC中SLC46A1的下调会导致叶酸缺乏,表观遗传改变和基因激活.
- SLC46A1表观遗传转录调节轴为CRC发展和潜在的治疗点提供了洞察力.
相关概念视频
Epigenetic Regulation
33.8K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
Epigenetic Regulation
3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.9K
mTOR Signaling and Cancer Progression
4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.8K
Transcription Factors
82.7K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.7K
Prokaryotic Transcriptional Activators and Repressors
25.5K
The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
Transcription of prokaryotic...
25.5K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K


